Literature DB >> 22785452

The efficacy of FDG-PET for the management of esophageal cancer: review article.

Hiroyuki Kato1, Masanobu Nakajima.   

Abstract

(18)F-Fluorodeoxyglucose positron emission tomography has become an important informative modality during the past two decades. Because this type of tomography is a functional imaging construct, its primary use is in the field of oncology. It is being used increasingly in the management of several tumor types including esophageal cancer. These tomography scans can distinguish between benign and malignant tumors, identify stages of tumor spread, assess tumor recurrence, and monitor the response of malignant disease to therapy. The aim of this review was to outline the current and future roles of positron emission tomography in the management of esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785452     DOI: 10.5761/atcs.ra.12.01954

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  9 in total

1.  Diagnostic value of ¹⁸F-FDG PET/CT for lymph node metastasis of esophageal squamous cell carcinoma.

Authors:  Hiroyuki Yamada; Masao Hosokawa; Kazuo Itoh; Toshinao Takenouchi; Yoshihiro Kinoshita; Tomohiro Kikkawa; Keita Sakashita; Shion Uemura; Yasunori Nishida; Takaya Kusumi; Shigeyuki Sasaki
Journal:  Surg Today       Date:  2014-07       Impact factor: 2.549

Review 2.  Towards precision medicine: from quantitative imaging to radiomics.

Authors:  U Rajendra Acharya; Yuki Hagiwara; Vidya K Sudarshan; Wai Yee Chan; Kwan Hoong Ng
Journal:  J Zhejiang Univ Sci B       Date:  2018 Jan.       Impact factor: 3.066

Review 3.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

Authors:  Muhammad Kashif Rahim; Sung Eun Kim; Hyeongryul So; Hyung Jun Kim; Gi Jeong Cheon; Eun Seong Lee; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-01-22

4.  PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.

Authors:  Ray Y Chen; Lori E Dodd; Myungsun Lee; Praveen Paripati; Dima A Hammoud; James M Mountz; Doosoo Jeon; Nadeem Zia; Homeira Zahiri; M Teresa Coleman; Matthew W Carroll; Jong Doo Lee; Yeon Joo Jeong; Peter Herscovitch; Saher Lahouar; Michael Tartakovsky; Alexander Rosenthal; Sandeep Somaiyya; Soyoung Lee; Lisa C Goldfeder; Ying Cai; Laura E Via; Seung-Kyu Park; Sang-Nae Cho; Clifton E Barry
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

5.  Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.

Authors:  Nandakumar Menon; Mark Mandelkern
Journal:  Dig Dis Sci       Date:  2022-07-30       Impact factor: 3.487

6.  Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Yoshiaki Nakabeppu; Masayuki Nakajo; Ryutarou Higashi; Yoshihiko Fukukura; Ken Sasaki; Yasuto Uchikado; Shoji Natsugoe; Takashi Yoshiura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-10       Impact factor: 9.236

7.  Late Recurrence After Radical Resection of Esophageal Cancer.

Authors:  Yukiharu Hiyoshi; Naoya Yoshida; Masayuki Watanabe; Junji Kurashige; Ryuichi Karashima; Shiro Iwagami; Yoshifumi Baba; Hideo Baba
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

8.  Prognostic Value of Functional Parameters of 18F-FDG-PET Images in Patients with Primary Renal/Adrenal Lymphoma.

Authors:  Manni Wang; Hui Xu; Liu Xiao; Wenpeng Song; Sha Zhu; Xuelei Ma
Journal:  Contrast Media Mol Imaging       Date:  2019-07-25       Impact factor: 3.161

9.  Prognostic Assessment of Interim F18-Fluorodeoxyglucose Positron Emission Tomography in Esophageal Cancer Treated With Chemoradiation With or Without Surgery.

Authors:  Sophie Lavertu; Maroie Barkati; Sylvain Beaulieu; Jocelyne Martin; Marie-Pierre Campeau; David Donath; David Roberge
Journal:  Cureus       Date:  2022-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.